Rebecca Liang serves as a Senior Analyst at Bernstein, where she conducts equity research with a specific focus on the pharmaceutical and biotech industries in China. Her analysis contributes to understanding market dynamics and investment opportunities within these sectors.

Prior to her role at Bernstein, Liang gained significant experience in strategy and management.